Search

everythinglearnresearchcommunity

for

Search:↓

Skin tags in obese individuals may indicate higher cardiovascular risk.

Polycystic Ovary Syndrome (PCOS) is common in infertile women and obese women with PCOS have more severe ovulatory problems, needing more care.

People with PCOS, especially if obese, often have NAFLD, linked to obesity, insulin resistance, and high androgen levels.

Lifestyle changes improve metabolism and fertility in overweight PCOS patients; anti-obesity drugs show potential but need more research.

Bariatric surgery may help severely obese teenagers but has risks and requires careful patient selection and long-term care.

Older, obese people with many COVID-19 symptoms are more likely to suffer from severe long-term COVID-19 effects.

Healthy lifestyle changes, especially weight loss, can improve symptoms and overall health in people with Polycystic Ovary Syndrome, especially if they are overweight or obese.

Bariatric surgery can worsen nutritional deficiencies, requiring careful monitoring and supplementation.

Sleeve gastrectomy leads to significant weight loss and health improvements with few complications.

Obesity is an independent risk factor for early coronary artery disease (CAD) and its severity is not affected by age.

Obesity can cause various skin problems, with differences in prevalence between males and females.

Obesity is linked to more severe lower urinary tract symptoms.

Higher levels of small, dense LDL cholesterol are linked to a greater risk of heart attack in young adults.

Transvaginal hydrolaparoscopy is effective for increasing ovulation and pregnancy rates in women with PCOS who didn't respond to clomiphene.

Blocking the enzyme 11β-HSD1 might help treat obesity and metabolic issues.

PCOS is often linked to insulin resistance and obesity, and weight loss can improve symptoms.

Skin problems like acne and excess hair in PCOS are common and linked to being overweight.

Metformin and thiazolidinediones are similarly effective for PCOS, but metformin is often preferred due to fewer side effects.

Many young Egyptian women with PCOS also have fatty liver disease, especially if they are overweight and insulin resistant.

Some blood-thinning medications can increase the risk of bleeding, and certain factors like genetics and other health conditions affect their safety and effectiveness.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

Eating 500 fewer calories a day and making lifestyle changes can improve PCOS symptoms and reduce diabetes risk; more research is needed on its causes and treatments.

GLP-1 receptor agonists, like Dulaglutide, Liraglutide, and Semaglutide, have potential benefits beyond the pancreas, including neuroprotection, pain suppression, cardiovascular protection, obesity management, and cancer treatment, but there are concerns about pancreatitis and pancreatic cancer risks.

Cyproterone acetate is effective for treating hirsutism and acne but less so for hair loss, with side effects similar to birth control pills.

The French Endocrine Society suggests diagnosing PCOS with two of three signs, recommends lifestyle changes and clomiphene for treatment, and calls for more research on certain treatments and tests.

Weight loss and metformin don't significantly change vaspin levels in women with PCOS.

More pediatric-specific research and guidelines are needed to improve hidradenitis suppurativa treatment in children and adolescents.

Eating disorders can cause skin problems that need treating the underlying condition for better health.

Both metformin and pioglitazone improve PCOS symptoms, but pioglitazone is a good alternative for those who can't take metformin.

Leptin affects skin and hair health and may worsen some skin conditions, but more research is needed to understand its full impact.